SGLT2 inhibitors and angiotensin receptor neprilysin inhibitors (ARNis) are the ‘new kids on the block’ in the latest update of national heart failure guidelines. The National Heart Foundation of Australia and CSANZ Guidelines for the Prevention, Detection and Management of Heart Failure in Australia 2018, launched at the 2018 Cardiac Society of Australia and New Zealand ...
Type 2 diabetes
SGLT2 inhibitors are ‘the new kids on the block’ in heart failure guidelines
By Mardi Chapman
8 Aug 2018